Online Webinar
24 Sep
Health
Orphan Drugs Market Access and Regulatory Affairs
Many blockbuster drugs will lose their exclusivity in the next five years. Therefore, the current economic situation has shifted the focus of many pharmaceutical companies from essential medicines to orphan drugs.
Sign in to display more details